Tuberculosis Clinical Trials Consortium Study 35
Conditions
Interventions
- DRUG: Rifapentine
- DRUG: Isoniazid
Sponsor
Centers for Disease Control and Prevention
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]